Page last updated: 2024-11-05

trifluoperazine and Neurilemmoma

trifluoperazine has been researched along with Neurilemmoma in 1 studies

Neurilemmoma: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brosius, SN1
Turk, AN1
Byer, SJ1
Longo, JF1
Kappes, JC1
Roth, KA1
Carroll, SL1

Other Studies

1 other study available for trifluoperazine and Neurilemmoma

ArticleYear
Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.
    Journal of neuropathology and experimental neurology, 2014, Volume: 73, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Drug Delivery Systems;

2014